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ABSTRACT 
Background/Objectives: A small number of case-control studies have suggested that 
mitochondrial haplogroups could be associated with obesity. We examined whether obesity 
risk was influenced by mitochondrial haplogroup in a large North American cohort across an 
8 year period. We conducted a longitudinal cohort study including individuals from the 
Osteoarthritis Initiative. 
Subjects/Methods: Mitochondrial haplogroups were determined by sequencing and PCR-
RFLP techniques using this nomenclature: HV, JT, KU, IWX, and superHV/others. The 
strength of the association between mitochondrial haplogroups and incident obesity was 
quantified with hazard ratios (HRs) adjusted for potential confounders using Cox’s regression. 
Results: Overall, 2,342 non-obese Caucasian participants (56.7% women) with a mean±SD 
age of 62.0±9.5 years at baseline were included. During a median follow-up of 8 years, 334 
individuals (=14.3% of baseline population) became obese. After adjusting for 9 potential 
confounders the haplogroups IWX carried a significant 48% higher risk of obesity (HR=1.48; 
95%CI: 1.02-2.39) compared to the HV haplotype (the most frequent type). 
Conclusion: Only the presence of the IWX haplogroups appears to be linked to increased 
obesity risk, independent of potential baseline confounders. Future cohort studies are needed 
with independent data are needed to confirm these findings and to  determine potential 
underlying mechanisms.   
 
Keywords: mitochondrial haplogroups; obesity; BMI; Osteoarthritis Initiative.  
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INTRODUCTION 
The mitochondrial genome is a circular set of about 17,000 base pairs encoding 37 genes in 
human beings. Of them, 13 are translated in proteins that are involved in a diverse range of 
processes relevant to cellular function and survival, e.g. electron transport and oxidative 
phosphorylation.1 Mitochondrial DNA (mtDNA) often undergoes pathological changes and is 
reported that repair mechanisms are less efficient than nuclear DNA.1, 2 In addition, the 
mtDNA evolves much more quickly than average nuclear DNA, with mutations therefore 
accumulating sequentially along radiating maternal lineages.3 Mitochondrial haplogroups are 
defined as specific groups of single nucleotide polymorphisms (SNPs) which result from 
mismatches, and it has been increasingly recognized that different mitochondrial haplogroups 
may influence propensity to several chronic disease states. 4-6 
 
Mitochondria are essential in energy metabolism, and thus mitochondrial dysfunction could 
affect obesity.7 However, the literature regarding the possible association between 
mitochondrial haplogroups and obesity is still limited to a small number of case-control 
studies. In 2,286 Caucasians of Northern European origin living in the USA, Yang et al. 
found that haplogroup X, mt4823 and mt8873 were related to lower body mass index (BMI) 
and decreased body fat mass.8 Similarly, in an Italian study including 500 obese cases vs. 216 
controls, obese people demonstrated greater frequency of haplogroup T and reduced 
frequency of haplogroup J compared to healthy controls.9 Finally, in another more recent 
case-control study involving 1,251 obese people vs. 861 normal weight individuals, 
haplogroup T was found to be more frequent in obese people.10 
 
Whilst these studies have advanced our knowledge regarding the possible association between 
mitochondrial haplogroups and obesity, a number of limitations persists. First, they all rely on 
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a case-control study design, thus their nature does not allow the authors to infer a cause-effect 
direction. Second, these studies did not control for any possible confounders (e.g. physical 
activity or educational level or the presence of other co-morbidities), and it is possible that 
residual confounding exists. 
 
As little or no longitudinal research has investigated the influence of mitochondrial 
haplogroups on incident obesity, and some previous case-control studies have reported 
insignificant associations between mitochondrial haplogroups and obesity 11, we sought to 
determine whether obesity risk was linked to different  mitochondrial haplogroups in a large 
prospective cohort of North American people.     
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METHODS 
Data source and participants 
Data used in this study were obtained from the Osteoarthritis Initiative (OAI) 
(http://www.oai.ucsf.edu), a large ongoing nationwide study sponsored by the National 
Institute of Health. Data was based on patients recruited between February 2004 and May 
2006 from the following four clinical sites in the US with a high risk of knee osteoarthritis. 
Specific data used in the current study were: baseline and screening evaluations (V00; 
November 2008), and assessments until the final (96 month) available evaluation (V01, V03, 
V05, V06, V08, V10). Written informed consent provided by all subjects. 
 
Exposure 
Haplogroup assignment was determined by PCR-RFLP and sequencing methods using 
established methods12. The latter consisted of the multiplex assignment of the six main SNPs 
that contribute to the generation of the most prevalent Caucasian haplogroups 13 (H, V, super 
HV, U, K, T, J) following the single base extension (SBE) assay.  
 
In line with OAI nomenclature,  haplogroups were as follows: H, U, K, J, T, V, SuperHV, I, 
W, X or Others. We consequently clustered these haplogroups following the classification 
suggested by MITOMAP and followed by another study assessing mitochondrial haplogroups 
and cardiovascular disease (CVD)14, 15 into HV, JT, KU, IWX, and superHV/others.  
 
Outcomes 
In the OAI, a trained nurse measured weight and height with standardized methods. Weight 
was recorded without shoes, heavy jewelry, or wallets, and in lightweight clothing in Kg. 
Height was measured without shoes, using the required breathing technique during each 
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measurement. Two initial measurements were made, with the participant a step away from the 
stadiometer, then step back into the measurement position. If the difference between these 
two measurements was greater than 4 mm, other two measurements were made. Height was 
recorded in mm. BMI > 30 kg/m2 in agreement with the guidelines suggested by the Word 
Health Organization (WHO)16 and computed as weight/height2 These measures were repeated 
at each visit, i.e. V01, V03, V05, V06, V08, and V10.  
 
Covariates 
Obesity risk across mitochondrial haplogroups was examined after controlling for the 
following potential confounders (1) baseline BMI; (2) physical activity, using PACE17, which 
assesses 12 different physical activities (e.g. walking, housework). It is scored on a 0-400 
scale and has been validated in older populations; (3) smoking habits  (previous/current vs. 
never); (4) education ( degree vs. lower levels); (5) annual income (>$50,000 vs. <$50,000 
or missing data); (6) co-morbidities, quantified with the modified Charlson scale (higher 
scores indicate greater severity); and (7) total energy intake (in daily Kcal) assessed with a 
food frequency questionnaire.18  
Statistical analyses 
Means and standard deviations (continuous outcomes) and count percentage (categorical 
outcomes) were computed for mitochondrial haplogroups, with ANOVA and Pearson’s chi-
square used as corresponding inferential tests. Normality was assessed with the Kolmogorov-
Smirnov test. We used Levene’s test to assess equality of variance, with Welch’s ANOVA 
used in the event of any violation of this assumption. Post-hoc analyses were run and 
Bonferroni adjustments were applied. The haplotype HV (the most common) was used as the 
reference group in all comparisons. 
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Proportional hazards (Cox) regression was used to quantify the magnitude of the  association 
of mitochondrial haplogroups and incident obesity, with an outcome of  time to the onset of 
obesity or to the last observation made. All the analyses excluded individuals with obesity at 
baseline. Participant attrition due to death was censored at the date of death.  
 
Factors associated with obesity at follow-up in the univariable analysis were included in the 
model. A VIF (variance inflation factor) of >=2 was used as a threshold for multicollinearity  
The baseline model was adjusted for age and sex, while the fully-adjusted model also 
controlled for baseline BMI, education, smoking, income, co-morbidity , physical activity and 
daily energy intake (see previous section for how these variables were categorized). . Hazard 
ratios (HRs) with 95% confidence intervals (CIs) were used as the primary outcome statistic. 
 
Analyses were conducted with SPSS 17.0, with using p<.05 used to indicate significance. 
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RESULTS 
Participants 
Haplogroup data was not available for 1,047 of 4,796 participantswith data from a further 126 
excluded due to technical problems. Moreover, 1,167 people were already obese at baseline, 
whilst other 114 were lost at follow-up. Therefore, the final sample of the current study 
consisted of 2,342 eligible individuals (Figure 1).    
 
Baseline analyses  
The 2,342 participants included had a mean age of 62.0±9.5 (45-79) years, with slightly more 
women (=56.7%). All the participants included were Caucasian and the mean±SD BMI at 
baseline was 25.6±2.7 Kg/m2.  
Participant baseline characteristics by mitochondrial haplogroup are reported in Table 1. The 
HV group was the most frequent haplotype (n=1,051; =44.9%) and was used as the reference 
in all the elaborations. Compared to the HV haplogroup, there were no significant differences 
in age, sex, physical activity level, smoking, comorbidity, or energy intake demonstrated 
across other haplogroups. Participants having IWX haplotype (n=100) consisted of a 
significantly higher prevalence of highly educated people (p=0.02), but these participants 
were significantly richer (p=0.01) than the reference group (HV). Finally, the 142 having 
super HV/other mitochondrial haplotype showed significantly higher BMI values than people 
with HV haplotype (Table 1).  
 
Association between mitochondrial haplogroups and incident obesity 
After a median period of 8 years, 334 individuals (14.3% of baseline population) developed 
obesity.  
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As shown in Table 2, the incidence of obesity was higher in people with the haplotype IWX 
(31; 95%CI: 20-48 per 1,000 persons-year) and others/superHV haplogroups (35; 95%CI: 25-
50 per 1,000 persons-year) compared to the reference group, HV (22; 95%CI: 18-25 per 1,000 
persons-year) (Figure 1).  
  
Using a Cox’s regression analysis adjusted for nine demographic and clinical potential 
confounders and taking people with the HV haplotype as reference, the haplogroup IWX 
carried a significantly higher risk for obesity by about 48% (HR=1.48; 95%CI: 1.02-2.39) 
(Table 2).  
DISCUSSION 
To the best of our knowledge, the current study is the first longitudinal investigation of the 
relationship between mitochondrial haplogroups and obesity in a cohort of community dwelling 
adults. We found that over a follow-up period of 8 years, people who had an IWX haplotype 
(n=100; =4.2% of the baseline population) were approximately 48% more likely to develop obesity 
compared to the most frequent haplotype (HV). This finding remained significant even when 
accounting for several potential confounders assessed at baseline which are known to influence the 
risk of obesity, such as physical activity and education status.   
 
It is noteworthy that at baseline, participants with the IWX haplotype did not have any significant 
difference in potential risk factors for obesity, such as baseline BMI. However, after 8 years of 
follow-up, the IWX haplogroup carried a sizeable and consistent increase of nearly 50% in obesity 
incidence, suggesting an important role of these haplotypes for this condition. In contrast to 
previous literature regarding this topic, haplogroup T was not linked to obesity. However, in the 
most recent study regarding the possible association between mitochondrial haplogroups and 
obesity, the relationship between haplogroup T and juvenile obesity disappeared after adjustment 
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for multiple testing.10 Several reasons can explain the differences between our study and those 
reporting a significant association between haplogroup T and obesity. First, we used a different 
categorization of mitochondrial haplogroups compared to the case control studies mentioned and 
consequently a different reference group. In particular, we grouped the group T with the J as 
suggested by MITOMAP and in agreement with other works suggesting that mitochondrial 
haplogroup J and T form a cluster with shared polymorphisms (e.g. mtDNA T4216C) and were 
formerly described as sister haplogroups with a common root. 19 Second, the design of our study 
(longitudinal vs. case control) may lead to different results.  
 
The precise reason why the IWX haplogroup is linked to obesity is unclear and clearly warrants 
investigation. One potential reason may be that participants of these haplogroups may have had 
lower energy expenditure and higher fat accumulation. In a study including 231 subjects suffering 
from AIDS, the ten people of haplogroup I exhibited higher baseline extremity fat compared to 
other haplogroups, whilst those in haplogroup W had the greatest increase in extremity fat over 96 
months of follow-up. 20 However, other studies are needed to confirm these findings coming from a 
special population.  
 
Our findings are of importance since obesity is increasing worldwide. As recently as 2010, 3.4 
million deaths were linked to obesity, as well as nearly 4% of disability-adjusted life-years 
worldwide.21 While there are clearly substantive environmental contributions to obesity, genetic 
components are also likely to contribute with heritability estimates of 40-70% suggested.22 Obesity 
is a multi-factorial disease due to an interaction between environmental and genetic factors. Among 
genetic factors, Genome-Wide Association Studies (GWAS) suggested that a core network module 
in humans and mice is possible. This network module is rich of genes involved in the inflammatory 
and immune response and probably play a role for obesity-related traits.23 For a long time, it was 
discussed if a person may become obese for a low energy expenditure or for a too high energy 
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intake with diet. 24 Low energy expenditure is traditionally seen as risk factor for obesity. In 
industrialized countries, it is common for half of a  waking day sitting and the other half consisting 
of low volume physical activity.25 Recent studies suggest that the low energy expenditure resulting 
from this low level of activity may have a significant direct relationship with obesity.26 However, 
more recent studies proposed that high energy intake may have a more important role than low 
energy expenditure in determining obesity.27 The role of genetic factors in determining obesity is 
very conflicting and still debated. As shown by several studies 28, 29, most people probably have 
some genetic predisposition to obesity, but the movement from genetic predisposition to obesity 
itself requires a strong interaction with other environmental factors, such as diet and lifestyle. 30 
However, contrary to the literature regarding nuclear DNA, the literature regarding mitochondrial 
haplogroups is still limited, but could be of importance since the sequencing of the complete 
mtDNA genome is now readily available, and in the coming era of personalized medicine, these 
types of genetic discoveries may integrate these information into clinical practice, for tailored 
therapeutic intervention strategies.31 
 
It is important to note that these findings should be treated cautiously. First, data were only 
available for Caucasians and thus cannot be automatically genralised to outside of this specific 
ethnic group. Second, the OAI study included only people with or at high risk of knee osteoarthritis, 
and so the same concerns about genralisability to  wider population must apply. These limitations 
notwithstanding, the large cohort included at baseline, the control for a number of important 
confounders and the long-follow-up period, make an important contribution to our understanding of 
how genetic haplotype may confer a vulnerability to obesity.  
.  
In conclusion, in our study, mitochondrial haplogroups IWX carried a significant higher risk of 
obesity compared to the most frequent haplogroups, HV. Future longitudinal studies in general 
population are however needed to confirm/refute our findings.  
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FIGURE LEGENDS 
 
Figure 1. Flow chart of the study 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Patients enrolled in the OAI study: 4,796 
Patients excluded and reasons: 
1,047: no data regarding mitochondrial haplogroups 
126: technical problems 
1,167: already obese at baseline 
114: lost at follow-up 
Patients included in the present study: 2,342 
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Table 1. Baseline characteristics by mitochondrial haplogroups.  
 
Notes: 
In all the comparisons, the group HV was taken as reference.  
***: p<0.0001; **: p<0.001; *: p<0.05. The Bonferroni’s correction was applied for continuous 
measures. 
Numbers are mean values (and standard deviations) or percentages, as appropriate. 
 
Abbreviations: BMI: body mass index; PASE:  physical activity scale for the elderly.  
Variable 
HV 
(n=1051) 
JT 
(n=467) 
KU 
(n=582) 
IWX 
(n=100) 
SuperHV/ 
others 
(n=142) 
Age (years) 61.7 (9.6) 62.1 (9.6) 62.8 (9.2) 61.7 (9.9) 61.8 (9.2) 
Females (%) 58.6 57.4 53.4 51.0 57.7 
PASE (points) 169 (92) 168 (101) 172 (105) 172 (77) 155 (81) 
Smoking (%) 43.9 44.5 45.9 45.0 45.8 
Degree (%) 36.5 35.5 36.8 42.0* 30.3 
Yearly income (<50,000 $) 67.6 68.5 66.7 56.0* 59.2 
Charlson co-morbidity score 0.3 (0.7) 0.3 (0.7) 0.3 (0.7) 0.4 (1.0) 0.4 (0.9) 
Energy intake (kcal/day) 1380 (511) 1343 (513) 1344 (537) 1404 (563) 1410 (511) 
BMI (Kg/m2) 25.6 (2.7) 25.5 (2.79 25.4 (2.7) 25.6 (2.9) 26.3 (2.7)* 
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Table 2. Association between mitochondrial haplogroups and incident obesity. 
  
Incidence 
(95% CI) 
per 1,000 persons-year 
Basic adjusted 
HR* 
(95%CI) 
P value 
Fully adjusted 
HR** 
(95%CI) 
P value 
HV 22 (18-25) 1 [reference] 1 [reference] 
JT 19 (15-25) 0.96 (0.71-1.299 0.77 1.05 (0.78-1.42) 0.74 
KU 19 (15-24) 0.92 (0.70-1.22) 0.57 1.03 (0.77-1.37) 0.85 
IWX 31 (20-48) 1.52 (1.08-2.45) 0.02 1.48 (1.02-2.39) 0.01 
Others/ SuperHV 35 (25-50) 1.62 (1.09-2.41) 0.02 1.14 (0.76-1.71) 0.54 
 
Notes: 
* Basic adjusted model includes age (as continuous) and sex.  
**Fully-adjusted model included as covariates: body mass index (as continuous) at baseline; education (degree vs. others); smoking habits (current 
and previous vs. others); yearly income (categorized as > or < 50,000$ and missing data); Charlson co-morbidity index (as continuous); Physical 
Activity Scale for Elderly score (as continuous); daily energy intake (as continuous).  
Abbreviations:  CI: confidence intervals; HR: hazard ratio. 
 
